General health and knee function outcomes from 7 days to 12 weeks after spinal anesthesia and multimodal analgesia for anterior cruciate ligament reconstruction.
General health and knee function outcomes from 7 days to 12 weeks after spinal anesthesia and multimodal analgesia for anterior cruciate ligament reconstruction.
复制标题
DOI:
10.1213/ane.0b013e318198d46e
复制
发表时间:
2009-04
影响因子:
5.7
通讯作者:
Kentor ML
中科院分区:
文献类型:
--
作者:
Williams BA;Dang Q;Bost JE;Irrgang JJ;Orebaugh SL;Bottegal MT;Kentor ML
We previously reported that continuous perineural femoral analgesia reduces pain with movement during the first 2 days after anterior cruciate ligament reconstruction (ACLR, n=270), when compared with multimodal analgesia and placebo perineural femoral infusion. We now report the prospectively collected general health and knee function outcomes in the 7 days to 12 weeks after surgery in these same patients. At 3 points during 12 weeks after ACLR surgery, patients completed the SF-36 General Health Survey, and the Knee Outcome Survey (KOS). Generalized Estimating Equations were implemented to evaluate the association between patient-reported survey outcomes and (i) preoperative baseline survey scores, (ii) time after surgery, and (iii) 3 nerve block treatment groups. Two-hundred-seventeen patients’ data were complete for analysis. In univariate and multiple regression Generalized Estimating Equations models, nerve block treatment group was not associated with SF-36 and KOS scores after surgery (all with P≥0.05). The models showed that the physical component summary of the SF-36 (P < 0.0001) and the KOS total score (P < 0.0001) increased (improved) over time after surgery and were also influenced by baseline scores. After spinal anesthesia and multimodal analgesia for ACLR, the nerve block treatment group did not predict SF-36 or knee function outcomes from 7 days to 12 weeks after surgery. Further research is needed to determine whether these conclusions also apply to a nonstandardized anesthetic, or one that includes general anesthesia and/or high-dose opioid analgesia.
登录
查看更多内容
影响因子:
1.9
作者:
Johnson, DS;Smith, RB
通讯作者:
Smith, RB
影响因子:
6.7
作者:
Williams, BA;DeRiso, BM;Watkins, WD
通讯作者:
Watkins, WD
影响因子:
8.8
作者:
Williams, BA;Kentor, ML;Fu, FH
通讯作者:
Fu, FH
影响因子:
8.8
作者:
Capdevila, X;Barthelet, Y;d'Athis, F
通讯作者:
d'Athis, F
DOI:
10.2106/00004623-199808000-00006
发表时间:
1998-08-01
影响因子:
5.3
作者:
Irrgang, JJ;Snyder-Mackler, L;Harner, CD
通讯作者:
Harner, CD